CompletedObservationalLast updated May 7, 2024

Study for Evaluation of Probiotics in the Re-equilibration of the Intestinal Microbiota, in Paediatric Age

Prospective Observational Study for the Evaluation of Probiotics Food Supplement in the Re-equilibration of the Intestinal Microbiota, in Paediatric Age

Overview

ClinicalTrials.gov ID: NCT06403358
Lead Sponsor: Labomar SPAINDUSTRY
Brief Summary: To evaluate the efficacy, safety and hydration index about the oral administration of probiotics food supplement in the re-equilibration of the intestinal microbiota, in presence of acute diarrhea
Study Type: Observational

Status

Overall Status: Completed
Start Date: Nov 28, 2022Actual
Primary Completion Date: May 26, 2023Actual
Completion Date: Jan 30, 2024Actual

Study Record Dates

First Submitted: Apr 19, 2024
First Submitted that Met QC Criteria: May 3, 2024
First Posted: May 7, 2024Actual
Last Update Submitted that Met QC Criteria: May 3, 2024
Last Update Posted: May 7, 2024Actual
Last Verified: May 2024

NCT06283784Completed

Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients

NCT01564290Completed

Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children

NCT02080130Withdrawn

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

NCT04944628Completed

Observational Prospective Study With Probiotic Supplementation on Infants With FGDI

NCT05524649Recruiting

Effect of Probiotics on Infant's Fecal Microbiota Composition

NCT04304014Completed

Assessment of the Impact of Type of Probiotic, Delivery Type and Feeding Type on Baby's Microbiota After Dysbiotic Delivery